Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Epithelial Yap/Taz are required for functional alveolar regeneration following acute lung injury
Gianluca T. DiGiovanni, … , Jonathan A. Kropski, Jason J. Gokey
Gianluca T. DiGiovanni, … , Jonathan A. Kropski, Jason J. Gokey
Published September 7, 2023
Citation Information: JCI Insight. 2023;8(19):e173374. https://doi.org/10.1172/jci.insight.173374.
View: Text | PDF
Research Article Pulmonology

Epithelial Yap/Taz are required for functional alveolar regeneration following acute lung injury

  • Text
  • PDF
Abstract

A hallmark of idiopathic pulmonary fibrosis (IPF) and other interstitial lung diseases is dysregulated repair of the alveolar epithelium. The Hippo pathway effector transcription factors YAP and TAZ are implicated as essential for type 1 and type 2 alveolar epithelial cell (AT1 and AT2) differentiation in the developing lung, yet aberrant activation of YAP/TAZ is a prominent feature of the dysregulated alveolar epithelium in IPF. In these studies, we sought to define the functional role of YAP/TAZ activity during alveolar regeneration. We demonstrated that Yap and Taz were normally activated in AT2 cells shortly after injury, and deletion of Yap/Taz in AT2 cells led to pathologic alveolar remodeling, failure of AT2-to-AT1 cell differentiation, increased collagen deposition, exaggerated neutrophilic inflammation, and increased mortality following injury induced by a single dose of bleomycin. Loss of Yap/Taz activity prior to an LPS injury prevented AT1 cell regeneration, led to intraalveolar collagen deposition, and resulted in persistent innate inflammation. These findings establish that AT2 cell Yap/Taz activity is essential for functional alveolar epithelial repair and prevention of fibrotic remodeling.

Authors

Gianluca T. DiGiovanni, Wei Han, Taylor P. Sherrill, Chase J. Taylor, David S. Nichols, Natalie M. Geis, Ujjal K. Singha, Carla L. Calvi, A. Scott McCall, Molly M. Dixon, Yang Liu, Ji-Hoon Jang, Sergey S. Gutor, Vasiliy V. Polosukhin, Timothy S. Blackwell, Jonathan A. Kropski, Jason J. Gokey

×

Figure 3

YAP/TAZ deletion prior to bleomycin injury leads to altered epithelial cell populations, activated fibroblast, and disrupted immune response.

Options: View larger image (or click on image) Download as PowerPoint
YAP/TAZ deletion prior to bleomycin injury leads to altered epithelial c...
(A) Schematic of experimental strategy to generate single-cell RNA-Seq analysis from mouse lungs. (B and C) UMAP embedding demonstrating clustering of the 29 cell types identified in the mouse lungs (B) and depicting cells recovered from respective genotype and treatment groups (C). (D–F) Relative proportions of each cell types/states within total cell populations (D), epithelial cell populations (E), and fibroblast cell populations between each treatment group (F). (G and H) Dot plot showing expression levels of AT2 cell lineage markers (G) and intermediate epithelial cell marker expression (H) in each treatment group. (I) Violin plot showing relative expression of activated fibroblast markers in WT or YTdel bleomycin-treated mice. (J) Output from LIANA demonstrating loss of Factor 4 ligand-receptor signaling in YTdel mice. (K) Gene ontology–associated programs identified as misregulated by LIANA. (L) Relative proportions of immune cell populations from each treatment group. (M) Flow cytometry analysis of immune cell subpopulations present in mice 7 days after bleomycin injury. n = 3 WT saline- and YTdel saline-, n = 5 WT bleomycin- and YTdel bleomycin-treated mice. (N) Dot plot showing expression of Ccl2 in intermediate alveolar epithelial cells and activated (including both intermediate and activated from F) fibroblast population.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts